Serum Institute seeks GoI’s approval to put ‘COVOVAX’ on Co-WIN Portal

Apr 12, 2022

New Delhi, Apr 12 (ANI): ‘COVOVAX’, a vaccine manufactured by Serum Institute of India awaits approval from the Government of India to be put in the Co-WIN Portal, informed CEO Adar Poonawalla on April 12. “COVOVAX will be used for children. It has been approved by DCGI and we are waiting for the Government of India to allow us to put it on the Co-WIN app to make it available to everyone. If it's taken in the government program, then we'll charge the same price of Rs 225 even for the private market,” said CEO Poonawalla.